Ulta美容 ULTA 深 滬
等待開盤 09-26 09:30:00 美东时间
545.20
-3.580
-0.65%
華盛通- 最 高553.035
- 今 開550.74
- 成交量 31.37万股
- 最 低 541.3217
- 昨 收 548.78
- 總市值 233.11亿
- 52周最高 714.9699
- 市盈率 靜 21.27
- 換手率 0.73%
- 52周最低 443.60
- 委 比 55.34%
- 總股本 4275.75万
- 歷史最高 714.9699
- 量 比 0.56
- 振 幅 2.13%
- 歷史最低 47.28
- 每 手 1
- 風險率 65.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Five Below Appoints Scott Settersten to its Board of Directors
Five Below appoints Scott Settersten, former CFO of Ulta Beauty, to its Board of Directors and Audit Committee. Settersten brings extensive financial and operational expertise, having led Ulta Beauty's finance and growth strategies. His addition reflects Five Below's focus on scaling its retail business and driving long-term value.
09-23 20:01
美妆、健康与康养赛道正在融合为同一个零售品类
核心要点 随着消费者愈发看重整体性消费采购，美妆、健康与康养逐渐归为同一大品类，消费者也将其归入同一笔消费预算。 各品类之间的边界日渐模糊，专家表示，能够...
09-18 20:22
美股大行评级 | 巴克莱大幅升Strategy目标价至160美元！康宁遭看淡至180美元，较现价仍溢价25%
今日重点评级关注：HC Wainwright & Co.：上调Cardiff Oncology评级至"买入"，目标价9美元；古根海姆：维持Inventiva"买入"评级，目标价从11美元升至14美元
09-16 16:10
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
BMO Capital Initiates Coverage On Ulta Beauty with Market Perform Rating, Announces Price Target of $580
BMO Capital analyst Kelly Crago initiates coverage on Ulta Beauty (NASDAQ:ULTA) with a Market Perform rating and announces Price Target of $580.
09-09 21:01
高盛分析师建议投资者把握近期股价回调机会逢低布局，5只“买入”评级标的：阿里巴巴、Burlington Stores（折扣服饰零售商）、Ulta Beauty（美妆零售）、Aecom（工程基建）、Viking Holdings（豪华邮轮）。
高盛分析师建议投资者把握近期股价回调机会逢低布局，5只“买入”评级标的：阿里巴巴、Burlington Stores（折扣服饰零售商）、Ulta Beauty...
09-05 22:37
Ulta Beauty Earnings Call Shows Confident Growth Outlook
Ulta Beauty (($ULTA)) has held its Q2 earnings call. Read on for the main highl...
09-05 08:03
S&P 500 gainers: Today’s top performers ranked by Quant
As August draws to a close, investors are preparing for September, a month that has historically presented one of the more challenging seasonal backdrops for the broader U.S. equity market. According ...
08-31 23:38
美股大行评级 | 潜在涨幅768.26%！Ascendiant Capital维持RenovoRx(RNXT)"买入"评级，目标价上调至14.5美元
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从14美元升至14.5美元；HC Wainwright & Co.：维持Generate Biomedicines"买入"评级，目标价从25美元升至30美元
08-31 18:14
